Literature DB >> 31949869

Association of GCKR rs780094 polymorphism with circulating lipid levels in type 2 diabetes and hyperuricemia in Uygur Chinese.

Li Wang1, Qi Ma1, Hua Yao1, Li-Juan He2, Bin-Bin Fang3, Wen Cai4, Bei Zhang5, Zhi-Qiang Wang2, Yin-Xia Su6, Guo-Li Du7, Shu-Xia Wang6, Zhao-Xia Zhang8, Qin-Qin Hou3, Ren Cai3, Fang-Ping He9.   

Abstract

To investigate the relationship between a GCKR rs780094 polymorphism and lipid profiles in the Xinjiang Uygur population in China. 980 type 2 diabetes mellitus (T2DM) patients, 1017 hyperuricemia (HUA) and 1185 healthy controls were included in this study. After genotyping of rs780094 by Sequenom Mass ARRAY system, chi-square test and logistic regression analysis were used for association analysis as well as a genotype-phenotype analysis. We found that the serum concentration of TC (P<0.001) was significantly higher and HDL-C (P<0.001) was lower in T2DM than in control participants. Subjects with HUA had a significantly higher TG (P=0.003) and lower HDL-C (P<0.001) than control participants. Additionally, under the recessive model, rs780094 was shown to be associated with the risk of HUA (P=0.015, OR=1.311), particularly in males (P=0.047, OR=1.330). Subsequent interaction analysis between rs780094 and lipid parameters showed that the TG level was positively correlated with HUA in the rs780094- AA+AG carriers (P=0.005). The TC concentrations showed to be associated with T2DM in the rs780094- AA+AG carriers (P<0.001). The association between lipid parameters and gender showed that significantly higher TG levels (P<0.001) and lower HDL-C levels (P<0.001) were observed in female HUA. Higher LDL-C levels were found in male HUA (P=0.015). Moreover, statistically higher TC levels and lower HDL-C levels were found both in male and female T2DM cases (TC: male: P<0.001, female: P=0.014. HDL-C: male: P<0.001, female: P<0.001.).To conclude, our results demonstrated that different genotypes of rs780094 had different effects on blood lipids in HUA and T2DM patients in a Uygur population. Gender was also one of the factors influencing blood lipid levels. IJCEP
Copyright © 2018.

Entities:  

Keywords:  GCKR; dyslipidemias; hyperuricemia; type 2 diabetes

Year:  2018        PMID: 31949869      PMCID: PMC6962982     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  A genome-wide association study identifies novel risk loci for type 2 diabetes.

Authors:  Robert Sladek; Ghislain Rocheleau; Johan Rung; Christian Dina; Lishuang Shen; David Serre; Philippe Boutin; Daniel Vincent; Alexandre Belisle; Samy Hadjadj; Beverley Balkau; Barbara Heude; Guillaume Charpentier; Thomas J Hudson; Alexandre Montpetit; Alexey V Pshezhetsky; Marc Prentki; Barry I Posner; David J Balding; David Meyre; Constantin Polychronakos; Philippe Froguel
Journal:  Nature       Date:  2007-02-11       Impact factor: 49.962

2.  Analysis of genomic admixture in Uyghur and its implication in mapping strategy.

Authors:  Shuhua Xu; Wei Huang; Ji Qian; Li Jin
Journal:  Am J Hum Genet       Date:  2008-03-20       Impact factor: 11.025

3.  The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte.

Authors:  N de la Iglesia; M Mukhtar; J Seoane; J J Guinovart; L Agius
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

4.  Twenty-eight loci that influence serum urate levels: analysis of association with gout.

Authors:  A J Phipps-Green; M E Merriman; R Topless; S Altaf; G W Montgomery; C Franklin; G T Jones; A M van Rij; D White; L K Stamp; N Dalbeth; T R Merriman
Journal:  Ann Rheum Dis       Date:  2014-09-03       Impact factor: 19.103

5.  CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D.

Authors:  Katrín A Gunnarsdóttir; Maj-Britt Jensen; David Zahrieh; Richard D Gelber; Ann Knoop; Marco Bonetti; Henning Mouridsen; Bent Ejlertsen
Journal:  Breast Cancer Res Treat       Date:  2010-05-13       Impact factor: 4.872

Review 6.  Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management.

Authors:  Joe M Chehade; Margaret Gladysz; Arshag D Mooradian
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

7.  The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.

Authors:  Delma J Nieves; Miriam Cnop; Barbara Retzlaff; Carolyn E Walden; John D Brunzell; Robert H Knopp; Steven E Kahn
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

8.  GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?

Authors:  Márton Mohás; Péter Kisfali; Luca Járomi; Anita Maász; Eszter Fehér; Veronika Csöngei; Noémi Polgár; Eniko Sáfrány; Judit Cseh; Katalin Sümegi; Katalin Hetyésy; István Wittmann; Béla Melegh
Journal:  Cardiovasc Diabetol       Date:  2010-11-29       Impact factor: 9.951

9.  Exome-wide association study of plasma lipids in >300,000 individuals.

Authors:  Dajiang J Liu; Gina M Peloso; Haojie Yu; Adam S Butterworth; Xiao Wang; Anubha Mahajan; Danish Saleheen; Connor Emdin; Dewan Alam; Alexessander Couto Alves; Philippe Amouyel; Emanuele Di Angelantonio; Dominique Arveiler; Themistocles L Assimes; Paul L Auer; Usman Baber; Christie M Ballantyne; Lia E Bang; Marianne Benn; Joshua C Bis; Michael Boehnke; Eric Boerwinkle; Jette Bork-Jensen; Erwin P Bottinger; Ivan Brandslund; Morris Brown; Fabio Busonero; Mark J Caulfield; John C Chambers; Daniel I Chasman; Y Eugene Chen; Yii-Der Ida Chen; Rajiv Chowdhury; Cramer Christensen; Audrey Y Chu; John M Connell; Francesco Cucca; L Adrienne Cupples; Scott M Damrauer; Gail Davies; Ian J Deary; George Dedoussis; Joshua C Denny; Anna Dominiczak; Marie-Pierre Dubé; Tapani Ebeling; Gudny Eiriksdottir; Tõnu Esko; Aliki-Eleni Farmaki; Mary F Feitosa; Marco Ferrario; Jean Ferrieres; Ian Ford; Myriam Fornage; Paul W Franks; Timothy M Frayling; Ruth Frikke-Schmidt; Lars G Fritsche; Philippe Frossard; Valentin Fuster; Santhi K Ganesh; Wei Gao; Melissa E Garcia; Christian Gieger; Franco Giulianini; Mark O Goodarzi; Harald Grallert; Niels Grarup; Leif Groop; Megan L Grove; Vilmundur Gudnason; Torben Hansen; Tamara B Harris; Caroline Hayward; Joel N Hirschhorn; Oddgeir L Holmen; Jennifer Huffman; Yong Huo; Kristian Hveem; Sehrish Jabeen; Anne U Jackson; Johanna Jakobsdottir; Marjo-Riitta Jarvelin; Gorm B Jensen; Marit E Jørgensen; J Wouter Jukema; Johanne M Justesen; Pia R Kamstrup; Stavroula Kanoni; Fredrik Karpe; Frank Kee; Amit V Khera; Derek Klarin; Heikki A Koistinen; Jaspal S Kooner; Charles Kooperberg; Kari Kuulasmaa; Johanna Kuusisto; Markku Laakso; Timo Lakka; Claudia Langenberg; Anne Langsted; Lenore J Launer; Torsten Lauritzen; David C M Liewald; Li An Lin; Allan Linneberg; Ruth J F Loos; Yingchang Lu; Xiangfeng Lu; Reedik Mägi; Anders Malarstig; Ani Manichaikul; Alisa K Manning; Pekka Mäntyselkä; Eirini Marouli; Nicholas G D Masca; Andrea Maschio; James B Meigs; Olle Melander; Andres Metspalu; Andrew P Morris; Alanna C Morrison; Antonella Mulas; Martina Müller-Nurasyid; Patricia B Munroe; Matt J Neville; Jonas B Nielsen; Sune F Nielsen; Børge G Nordestgaard; Jose M Ordovas; Roxana Mehran; Christoper J O'Donnell; Marju Orho-Melander; Cliona M Molony; Pieter Muntendam; Sandosh Padmanabhan; Colin N A Palmer; Dorota Pasko; Aniruddh P Patel; Oluf Pedersen; Markus Perola; Annette Peters; Charlotta Pisinger; Giorgio Pistis; Ozren Polasek; Neil Poulter; Bruce M Psaty; Daniel J Rader; Asif Rasheed; Rainer Rauramaa; Dermot F Reilly; Alex P Reiner; Frida Renström; Stephen S Rich; Paul M Ridker; John D Rioux; Neil R Robertson; Dan M Roden; Jerome I Rotter; Igor Rudan; Veikko Salomaa; Nilesh J Samani; Serena Sanna; Naveed Sattar; Ellen M Schmidt; Robert A Scott; Peter Sever; Raquel S Sevilla; Christian M Shaffer; Xueling Sim; Suthesh Sivapalaratnam; Kerrin S Small; Albert V Smith; Blair H Smith; Sangeetha Somayajula; Lorraine Southam; Timothy D Spector; Elizabeth K Speliotes; John M Starr; Kathleen E Stirrups; Nathan Stitziel; Konstantin Strauch; Heather M Stringham; Praveen Surendran; Hayato Tada; Alan R Tall; Hua Tang; Jean-Claude Tardif; Kent D Taylor; Stella Trompet; Philip S Tsao; Jaakko Tuomilehto; Anne Tybjaerg-Hansen; Natalie R van Zuydam; Anette Varbo; Tibor V Varga; Jarmo Virtamo; Melanie Waldenberger; Nan Wang; Nick J Wareham; Helen R Warren; Peter E Weeke; Joshua Weinstock; Jennifer Wessel; James G Wilson; Peter W F Wilson; Ming Xu; Hanieh Yaghootkar; Robin Young; Eleftheria Zeggini; He Zhang; Neil S Zheng; Weihua Zhang; Yan Zhang; Wei Zhou; Yanhua Zhou; Magdalena Zoledziewska; Joanna M M Howson; John Danesh; Mark I McCarthy; Chad A Cowan; Goncalo Abecasis; Panos Deloukas; Kiran Musunuru; Cristen J Willer; Sekar Kathiresan
Journal:  Nat Genet       Date:  2017-10-30       Impact factor: 38.330

10.  The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.

Authors:  Martine Vaxillaire; Christine Cavalcanti-Proença; Aurélie Dechaume; Jean Tichet; Michel Marre; Beverley Balkau; Philippe Froguel
Journal:  Diabetes       Date:  2008-06-12       Impact factor: 9.461

View more
  2 in total

1.  Examining an Association of Single Nucleotide Polymorphisms with Hyperuricemia in Chinese Flight Attendants.

Authors:  Jianpin Ye; Zhiwei Zeng; Yuxian Chen; Zhenkun Wu; Qingwei Yang; Tao Sun
Journal:  Pharmgenomics Pers Med       Date:  2022-06-08

Review 2.  Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms.

Authors:  Jianan Zhao; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Cell Dev Biol       Date:  2022-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.